Structural overexpression of CCND1 in MCL tumor cells is a driving cytogenetic abnormality in MCL tumorogenesis.[1] However, given that CCND1 is a weak oncogene, the aggressive disease pattern always results from secondary cytogenetic events. The gene discussed is CCND1; the disease is mantle cell lymphoma.